SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024

SEGMENT INFORMATION

Schedule of Segment Information

b. Segment information:

	Year Ended December 31,
(U.S. dollars in thousands)	2022		2023		2024
Revenues from customers	$	47,638	$	65,494	$	53,399
Less:
Employee salaries and related expenses		19,388		24,075		21,780
Sub-contractors expense		24,181		14,008		8,682
interest expense		2,529		3,180		1,062
Interest income		(1,146)		(1,286)		(1,299)
Depreciation		1,086		1,191		1,304
Other segment expenses*		15,997		15,760		17,716
Income before income taxes		(14,397)		8,566		4,154
Taxes on income		530		254		1,222
Segment net income	$	(14,927)	$	8,312	$	2,932

* Other expenses included in net income includes raw materials, rent and utilities and others.

Schedule of Disaggregation of Revenues

c. The following table summarizes the Company’s disaggregation of revenues:

		Year Ended December 31,
(U.S. dollars in thousands)	2022		2023		2024
Gaucher disease:
Pfizer (Ireland)	$	12,403	$	12,522	$	12,617
Fiocruz (Brazil)	$	9,452	$	10,401	$	11,031
Fabry disease:
Chiesi (Italy)	$	3,437	$	17,495	$	29,333
Total revenues from selling goods	$	25,292	$	40,418	$	52,981
Revenues from license and R&D services	$	22,346	$	25,076	$	418